Skip to main content
SIGMA HEALTHCARE LIMITED logo

SIGMA HEALTHCARE LIMITED — Investor Relations & Filings

Ticker · SIG ISIN · AU000000SIG5 LEI · 529900BZSP3BK7GYAO50 ASX Wholesale and retail trade
Open in API
Filings indexed 1,635 across all filing types
Latest filing 2026-05-03 Capital/Financing Update
Country AU Australia
Listing ASX SIG

About SIGMA HEALTHCARE LIMITED

https://sigmahealthcare.com.au/

Sigma Healthcare Limited is a major pharmaceutical wholesaler and distributor focused on providing comprehensive logistics and supply chain solutions. The company operates an extensive distribution network that delivers prescription medicines, over-the-counter products, and health and beauty goods to community pharmacies. It provides integrated business support and marketing services to a portfolio of retail pharmacy brands, including Amcal, Guardian, PharmaSave, and Discount Drug Stores. Sigma also develops and distributes a range of private label products. By leveraging advanced distribution infrastructure and technology, the company facilitates the efficient flow of healthcare products from manufacturers to retail providers, ensuring consistent access to essential medicines and health services for the broader population.

Recent filings

Filing Released Lang Actions
Macquarie Australia Conference 2026 - Update 2 pages 241.0KB
Capital/Financing Update Classification · 95% confidence The document is an ASX release dated 4 May 2026 from Sigma Healthcare Limited. It provides updates on sales performance, a new joint venture for UK market entry, and a new supply chain distribution center in New Zealand. The content focuses on operational and strategic business updates rather than detailed financial statements or comprehensive financial performance data. There are no indications of quarterly or annual financial results, no detailed financial tables, and no mention of filing formal reports such as 10-K or interim reports. The document is a corporate announcement providing key business updates and strategic initiatives, typical of a Capital/Financing Update or general corporate update. Given the focus on business growth, joint ventures, and capital expenditure plans, the most appropriate classification is Capital/Financing Update (CAP). The document length (5308 characters) supports it being a full announcement rather than a brief notice or report publication announcement.
2026-05-03 English
Half Year Accounts 26 pages 2.0MB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Appendix 4D Half Year Financial Report' and is lodged with the Australian Securities Exchange (ASX) under ASX Listing Rule 4.2A.3, indicating it is a half-year financial report. It covers the half year ended 31 December 2025, with comparative data for the half year ended 31 December 2024. The text includes detailed financial statements such as profit or loss, balance sheet, cash flows, notes, and directors' report. It also contains an auditor's review report, which is typical for interim or quarterly reports. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement. The presence of detailed financial data and analysis confirms it is a substantive interim financial report. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2026
2026-02-25 English
Sigma Half Year Results Presentation 21 pages 2.2MB
Investor Presentation Classification · 95% confidence The document is titled '1H26 RESULTS PRESENTATION' and dated 26 February 2026. It contains detailed financial performance data for the first half of fiscal year 2026, including revenue, EBIT, NPAT, EPS, cash flow, balance sheet, and strategic growth pillars. The content includes operational highlights, financial metrics, and outlook commentary. The presence of a Q&A section in the agenda and the detailed financial and strategic discussion indicate this is a presentation typically used for investor communication after quarterly or half-year results. The document length is 15,000 characters, which is consistent with a detailed presentation rather than a brief announcement. There is no indication that this is a full annual report (10-K) or an audit report. It is not a transcript of a call but a prepared presentation. Therefore, the document fits best as an Investor Presentation (IP).
2026-02-25 English
Sigma Half Year Results ASX Release 4 pages 337.8KB
Interim / Quarterly Report Classification · 95% confidence The document is an ASX release dated 26 February 2026 from Sigma Healthcare Limited announcing its financial results for the half year ended 31 December 2025 (1H26). It contains detailed financial performance data including Normalised EBIT, NPAT, revenue, sales growth, net debt, and dividend declaration. The document also includes CEO commentary, outlook, and webcast details for an investor briefing. The presence of comprehensive financial figures and analysis for a half-year period indicates this is a detailed Interim / Quarterly Report rather than a brief earnings release or a simple announcement. The document length (7598 characters) supports it being a substantive report rather than a short announcement. Therefore, the appropriate classification is Interim / Quarterly Report (IR). H1 2026
2026-02-25 English
Dividend/Distribution - SIG 4 pages 15.5KB
Notice of Dividend Amount Classification · 100% confidence The document is titled 'Appendix 3A.1 - Notification of dividend / distribution' and contains detailed information about a dividend payment by Sigma Healthcare Limited, including the dividend amount, ex-date, record date, and payment date. It specifies the dividend type as ordinary and provides franked dividend details. The document is an announcement of the dividend amount and payment schedule rather than a full financial report or analysis. The length is 4270 characters, which is relatively short and consistent with a dividend announcement. Therefore, the document fits the category of 'Notice of Dividend Amount' (DIV).
2026-02-25 English
FY26 Half Year Results Information 6 pages 507.5KB
Interim / Quarterly Report Classification · 100% confidence The document is an ASX release dated 19 February 2026 from Sigma Healthcare Limited announcing the upcoming release of its FY26 Half Year results for the period ending 31 December 2025. It includes detailed financial data such as profit and loss statements, balance sheets, and cash flow statements for the half year period. The document contains comprehensive financial performance information, including pro-forma normalised comparisons and statutory financial statements. It also mentions a webcast presentation and Q&A session related to the half year results. The presence of detailed financial statements and analysis for a half year period clearly identifies this as an Interim / Quarterly Report rather than a mere announcement or presentation. The document length (over 10,000 characters) and inclusion of substantive financial data confirm it is a full interim report, not just a report publication announcement or webcast invitation. Therefore, the correct classification is Interim / Quarterly Report (IR). H1 2026
2026-02-18 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.